Clinical trials for

Macular Degeneration Choroidal Neovascularization

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-generated · Refreshed daily · Not medical advice.

RecruitingLarge-scale testing

Daegu, Namgu, South KoreaCheck eligibility →

RecruitingObservational

Portland, Oregon, United StatesCheck eligibility →

RecruitingInterventional

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingPost-approval study

Hong Kong, Hong KongCheck eligibility →

RecruitingLarge-scale testing

Daegu, South KoreaCheck eligibility →

RecruitingSafety & dosing

Iowa City, Iowa, United StatesCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Phoenix, Arizona, United States +4 moreCheck eligibility →

RecruitingInterventional

Singapore, SingaporeCheck eligibility →

RecruitingPost-approval study

Seoul, Seoul, South KoreaCheck eligibility →

RecruitingPost-approval study

Milan, Italy +4 moreCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Modesto, California, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Phoenix, Arizona, United States +4 moreCheck eligibility →

AI-generated · Refreshed daily · Not medical advice.

RecruitingLarge-scale testing

Daegu, Namgu, South KoreaCheck eligibility →

RecruitingObservational

Portland, Oregon, United StatesCheck eligibility →

RecruitingInterventional

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingPost-approval study

Hong Kong, Hong KongCheck eligibility →

RecruitingLarge-scale testing

Daegu, South KoreaCheck eligibility →

RecruitingSafety & dosing

Iowa City, Iowa, United StatesCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Phoenix, Arizona, United States +4 moreCheck eligibility →

RecruitingInterventional

Singapore, SingaporeCheck eligibility →

RecruitingPost-approval study

Seoul, Seoul, South KoreaCheck eligibility →

RecruitingPost-approval study

Milan, Italy +4 moreCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Modesto, California, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Phoenix, Arizona, United States +4 moreCheck eligibility →

12 trials · Recruiting

12

Trials actively recruiting patients for Macular Degeneration Choroidal Neovascularization

Trial status

Phase

Location